Elranatamab
ATC L01FX32 · 9 markets · 19 records
Elranatamab
Forms
AU 5 records · 5 strengths
- 76 mg/1.9 mLinjectionElrexfio
- 44 mg/1.1 mLinjectionElrexfio
- 76 mginjectionELREXFIO elranatamab 44 mg/1.1 mL solution for injection vial
- 44 mginjectionELREXFIO elranatamab 44 mg/1.1 mL solution for injection vial
Records without a stated strength · 1 Elrexfio
US 3 records · 2 strengths
GB 2 records · 2 strengths
- 76 mg/1.9 mLinjectionElrexfio 44mg/1.1ml solution for injection vials
- 44 mg/1.1 mLinjectionElrexfio 44mg/1.1ml solution for injection vials
CA 2 records · 1 strengths
- 40 mg/1 mLliquidElrexfio
SG 2 records · 2 strengths
- 76 mg/1.9 mLinjectionELREXFIO SOLUTION FOR INJECTION 44 MG/1.1 ML
- 44 mg/1.1 mLinjectionELREXFIO SOLUTION FOR INJECTION 44 MG/1.1 ML
HK 2 records · 1 strengths
Records without a stated strength · 1 ELREXFIO SOLUTION FOR INJECTION 44 MG/1.1 ML
ES 1 records · 1 strengths
- 40 mg/1 mLinjectionElrexfio
TW 1 records · 1 strengths
- 40 mginjectionELREXFIO 40mg/mL solution for癌適求注射液40毫克/毫升
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Elrexfio
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.